| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1542-0124(12)70081-2 |
| P698 | PubMed publication ID | 17508116 |
| P2860 | cites work | Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye | Q24794134 |
| Effect of androgen deficiency on the human meibomian gland and ocular surface | Q28141302 | ||
| Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? | Q28189953 | ||
| Prevalence of dry eye syndrome among US women | Q28196875 | ||
| Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye | Q28214408 | ||
| Corneal complications following abuse of topical anesthetics | Q28217063 | ||
| Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000-2005 | Q28266962 | ||
| Toxic Keratopathy Associated With Abuse of Low-Dose Anesthetic | Q29031981 | ||
| Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. | Q30813799 | ||
| Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface | Q30993840 | ||
| Laser in situ keratomileusis-induced neurotrophic epitheliopathy | Q31005755 | ||
| Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride | Q31029759 | ||
| Treatment of keratoconjunctivitis sicca with topical androgen | Q31926207 | ||
| Apoptosis of ocular surface cells in experimentally induced dry eye. | Q33185569 | ||
| A new method for tear film stability analysis using videokeratography | Q33186845 | ||
| Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. | Q33196311 | ||
| Chronic dry eye and regression after laser in situ keratomileusis for myopia | Q33200474 | ||
| Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. | Q33202369 | ||
| Dry eye after LASIK: comparison of outcomes for Asian and Caucasian eyes | Q33213607 | ||
| Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. | Q33267971 | ||
| Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease | Q33643546 | ||
| Congenital deficiency of meibomian glands | Q33645555 | ||
| Androgens and dry eye in Sjögren's syndrome | Q33692681 | ||
| Hydrogel lens dehydration and subjective comfort and dryness ratings in symptomatic and asymptomatic contact lens wearers | Q33877379 | ||
| The diagnosis and management of dry eye: a twenty-five-year review | Q34048201 | ||
| Effect of inflammation on lacrimal gland function. | Q34338027 | ||
| Tear film changes associated with normal aging | Q34389583 | ||
| The pathology of dry eye. | Q34391929 | ||
| Diagnosis of dry eye. | Q34391935 | ||
| Dry eye in diabetic patients | Q34402818 | ||
| Blinking is controlled primarily by ocular surface conditions | Q34432436 | ||
| A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada | Q34441489 | ||
| Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
| Effects of 13-cis-retinoic acid on the hamster meibomian gland | Q34561621 | ||
| Tear secretion and tear film function in insulin dependent diabetics | Q44529109 | ||
| Mutation of the FOXC2 gene in familial distichiasis | Q44623182 | ||
| The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity | Q44631963 | ||
| Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers. | Q44669090 | ||
| Semiquantitative interference study of fatty layer of precorneal film | Q44736757 | ||
| Dry eye signs and symptoms in women with premature ovarian failure | Q44760300 | ||
| Incidence of dry eye in an older population | Q44790453 | ||
| Gender differences of symptom reporting and medical health care utilization in the German population | Q44929862 | ||
| Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells | Q45158775 | ||
| Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren's syndrome. | Q45254744 | ||
| Sensitizing effect of substance P on corneal epithelial migration induced by IGF-1, fibronectin, or interleukin-6. | Q45280854 | ||
| Blink rates and disorders of movement | Q45305199 | ||
| The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys | Q46263628 | ||
| Hyperkeratinization in a rabbit model of meibomian gland dysfunction. | Q46481210 | ||
| Decreased corneal sensitivity in patients with dry eye. | Q46568356 | ||
| Tear film tests in Parkinson's disease patients | Q46646261 | ||
| Formation and rupture of the tear film | Q47991713 | ||
| Quantification of MUC5AC protein in human tears. | Q48520717 | ||
| Twenty-five years of contact lenses: the impact on the cornea and ophthalmic practice. | Q50241386 | ||
| Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. | Q50735512 | ||
| Meibomian gland dysfunction in patients with Sjögren syndrome. | Q50870035 | ||
| The casual level of meibomian lipids in humans. | Q51056332 | ||
| Self-reported dry eye disease across refractive modalities. | Q51454973 | ||
| Decrease in corneal sensitivity and change in tear function in dry eye. | Q51572017 | ||
| Effect of contact lens materials on tear physiology. | Q51702265 | ||
| A proposed mechanism for increased tear-film osmolarity in contact lens wearers. | Q51801900 | ||
| Comparing goblet cell densities in patients wearing disposable hydrogel contact lenses versus silicone hydrogel contact lenses in an extended-wear modality. | Q51813047 | ||
| Tear evaporimeter for measuring water evaporation rate from the tear film under controlled conditions in humans. | Q51856603 | ||
| Basic tear flow. Does it exist? | Q51874441 | ||
| European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. | Q51935782 | ||
| The performance of the contact lens dry eye questionnaire as a screening survey for contact lens-related dry eye. | Q52038320 | ||
| Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. | Q52250855 | ||
| FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome | Q52550343 | ||
| Differentiation of lipid tear deficiency dry eye by kinetic analysis of tear interference images. | Q53659029 | ||
| Importance of the lipid layer in human tear film stability and evaporation. | Q53976696 | ||
| Pheochromocytoma, medullary thyroid carcinoma, multiple mucosal neuroma. A variant of the syndrome. | Q54070122 | ||
| Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
| Tear production in vitamin A-responsive xerophthalmia. | Q55062950 | ||
| OCULAR SARCOIDOSIS | Q55506835 | ||
| Complete Androgen Insensitivity Syndrome | Q55982482 | ||
| Ocular surface changes induced by contact lens wear | Q56901085 | ||
| Conjunctival Epithelium Expression of HLA-DR in Dry Eye Patients | Q58205031 | ||
| Dry Eye and Dry Mouth in the Elderly | Q58760236 | ||
| Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis | Q61851332 | ||
| Is the lacrimal gland dispensable? Keratoconjunctivitis sicca after lacrimal gland removal | Q66916036 | ||
| Short-term, low-contrast visual acuity reduction associated with in vivo contact lens drying | Q67583403 | ||
| Congenital alacrima | Q67703751 | ||
| Meibomian gland dysfunction in chronic blepharitis | Q67969282 | ||
| Conjunctival cytology in asymptomatic wearers of soft contact lenses | Q68019283 | ||
| Tear film and ocular surface changes in a rabbit model of neurotrophic keratitis | Q68777259 | ||
| Age-related changes in precorneal tear film stability | Q69603526 | ||
| Ocular manifestations of the ectrodactyly, ectodermal dysplasia, cleft lip-palate syndrome | Q69804903 | ||
| Goblet cell response to vitamin A treatment for corneal xerophthalmia | Q70443783 | ||
| Ocular manifestation of polychlorinated biphenyls intoxication | Q70469162 | ||
| Dry eyes and video display terminals | Q70544639 | ||
| Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community | Q70607945 | ||
| Ocular evaporation in meibomian gland dysfunction and dry eye | Q70627892 | ||
| Blepharoplasty and the dry eye syndrome: guidelines for surgery? | Q70841338 | ||
| Tear flow and evaporation in patients with and without dry eye | Q71051693 | ||
| Ocular surface drying and tear film osmolarity in thyroid eye disease | Q71244779 | ||
| Absent meibomian glands in the ectrodactyly, ectodermal dysplasia, cleft lip-palate syndrome | Q71345330 | ||
| Increased tear evaporation in eyes with keratoconjunctivitis sicca | Q71701315 | ||
| A comparative study of tear evaporation rates and water content of soft contact lenses | Q71722902 | ||
| Evaluation of the lacrimal drainage function by the drop test | Q71760764 | ||
| Ocular surface changes and discomfort in patients with meibomian gland dysfunction | Q71780207 | ||
| Model for ocular tear film function | Q71792663 | ||
| Aqueous tear production in patients with neurotrophic keratitis | Q71792671 | ||
| Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye | Q71863611 | ||
| Quantitating the change in upper eyelid position during downgaze | Q72200118 | ||
| Human tear film electrolyte concentrations in health and dry-eye disease | Q72388245 | ||
| Schrimer test in Parkinson's disease | Q34653150 | ||
| Topical treatment with nerve growth factor for corneal neurotrophic ulcers | Q34746902 | ||
| Design principles and limitations of wave-front guided contact lenses | Q35139080 | ||
| Dry eye after haematopoietic stem cell transplantation | Q35307825 | ||
| Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. | Q35589561 | ||
| Functional aspects of the tear film lipid layer | Q35755125 | ||
| The role of the lacrimal functional unit in the pathophysiology of dry eye. | Q35755146 | ||
| Neural basis of sensation in intact and injured corneas | Q35755185 | ||
| Cicatricial pemphigoid and dry eye. | Q36195261 | ||
| Mucous membrane pemphigoid: an update | Q36262871 | ||
| Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going? | Q36275127 | ||
| Familial dysautonomia: update and recent advances | Q36508004 | ||
| Pediatric autonomic disorders | Q36526513 | ||
| Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. | Q36639890 | ||
| Dysfunctional tear syndrome: a Delphi approach to treatment recommendations | Q36653052 | ||
| Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome | Q36680491 | ||
| Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging | Q36701146 | ||
| Corneal light scattering and visual performance in myopic individuals with spectacles, contact lenses, or excimer laser photorefractive keratectomy. | Q36780207 | ||
| Meibomian gland disease. Classification and grading of lid changes | Q36791267 | ||
| Loss of parasympathetic innervation leads to sustained expression of pro-inflammatory genes in the rat lacrimal gland | Q37258291 | ||
| The importance of the precorneal tear film for the quality of optical imaging | Q37295478 | ||
| Allergic conjunctivitis and dry eye. | Q37324742 | ||
| Denervation of the lacrimal gland | Q37395935 | ||
| Immunopathogenesis of Sjogren's syndrome: "facts and fancy". | Q38246202 | ||
| Sjögren's syndrome. Proposed criteria for classification | Q39790521 | ||
| Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - shedding light on an unexpected splice mutation | Q40293550 | ||
| Congenital alacrima in Pierre Robin sequence | Q40495971 | ||
| Differential regulation of membrane-associated mucins in the human ocular surface epithelium. | Q40604818 | ||
| Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease | Q40621648 | ||
| Meibomian gland dysfunction | Q41089196 | ||
| Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum | Q41428610 | ||
| Meibomian Gland Morphology and Tear Osmolarity: Changes with Accutane Therapy | Q41956130 | ||
| Altered traffic to the lysosome in an ex vivo lacrimal acinar cell model for chronic muscarinic receptor stimulation. | Q42469533 | ||
| Impaired functional visual acuity of dry eye patients | Q42668504 | ||
| Classification criteria for Sjögren's syndrome | Q43050846 | ||
| Hormone replacement therapy and dry eye syndrome | Q43788868 | ||
| A new approach for better comprehension of diseases of the ocular surface | Q44020701 | ||
| A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. | Q44044012 | ||
| Nutrient intake in women with primary and secondary Sjögren's syndrome | Q44305227 | ||
| Lipid, lipase and lipocalin differences between tolerant and intolerant contact lens wearers | Q44377378 | ||
| Effects of ocular surface area and blink rate on tear dynamics | Q72566252 | ||
| Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca | Q72993423 | ||
| The effects of sensory and parasympathetic denervation on the kinases and initiation factors controlling protein synthesis in the lacrimal gland | Q73071651 | ||
| Gene expression and fat deposit in primary cultures of rat meibomian gland cells | Q73071837 | ||
| Baseline blink rates and the effect of visual task difficulty and position of gaze | Q73303323 | ||
| Distribution pattern of nervous tissue and peptidergic nerve fibers in accessory lacrimal glands | Q73304627 | ||
| Periductal Area as the Primary Site for T-Cell Activation in Lacrimal Gland Chronic Graft-Versus-Host Disease | Q73316505 | ||
| Responses of contact lens wearers to a dry eye survey | Q73401158 | ||
| Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys | Q73453484 | ||
| A survey of trachoma: the histopathology and the mechanism of progressive cicatrization of eyelid tissues | Q73907768 | ||
| Characterization of ocular surface symptoms from optometric practices in North America | Q74266175 | ||
| Prevalence of and risk factors for dry eye syndrome | Q74298539 | ||
| Contact lens drying and visual performance: the vision cycle with contact lenses | Q74370825 | ||
| Ocular surface and environmental changes | Q74441758 | ||
| Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface | Q74485001 | ||
| Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies | Q74610959 | ||
| Ophthalmologic features of Parkinson's disease | Q75338237 | ||
| Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms | Q77319402 | ||
| Morphological changes of the conjunctival epithelium in contact lens wearers evaluated by impression cytology | Q77421510 | ||
| Tear dynamics and dry eye | Q77429291 | ||
| The pathology of dry eye: the interaction between the ocular surface and lacrimal glands | Q77575256 | ||
| Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
| Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency | Q77752013 | ||
| Assessment of meibomian gland function in dry eye using meibometry | Q77884140 | ||
| Sex steroids, meibomian gland dysfunction and evaporative dry eye in Sjögren's syndrome | Q78465916 | ||
| Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction | Q78852996 | ||
| Tear film osmolarity: determination of a referent for dry eye diagnosis | Q79143768 | ||
| Neurotrophic keratitis | Q79314645 | ||
| Further analysis of the human spontaneous eye blink rate by a cluster analysis-based approach to categorize individuals with 'normal' versus 'frequent' eye blink activity | Q79350936 | ||
| Promotion of corneal epithelial wound healing by a tetrapeptide (SSSR) derived from IGF-1 | Q80024572 | ||
| Ocular cicatricial pemphigoid | Q80217376 | ||
| Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions | Q80243890 | ||
| Androgen status of the nonautoimmune dry eye subtypes | Q80265439 | ||
| Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347912 | ||
| Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007) | Q80347923 | ||
| Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells | Q83008486 | ||
| Tear water evaporation and eye surface diseases | Q93559742 | ||
| P433 | issue | 2 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 75-92 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | |
| P478 | volume | 5 |
| Q35956929 | 17-β-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cells |
| Q38076540 | 2. Contact lens care and ocular surface homeostasis |
| Q37562459 | 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost M |
| Q42192062 | A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue |
| Q37349869 | A Clinical Study of Subtype-based Prevalence of Dry Eye. |
| Q37729041 | A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice. |
| Q37732321 | A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers |
| Q37676992 | A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye. |
| Q64250951 | A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q37204567 | A field test of Web-based screening for dry eye disease to enhance awareness of eye problems among general Internet users: a latent strategy to promote health |
| Q30956506 | A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids |
| Q37606463 | A model for tear film thinning with osmolarity and fluorescein |
| Q34538059 | A mouse dry eye model induced by topical administration of benzalkonium chloride. |
| Q35906365 | A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma |
| Q47246663 | A murine model of dry eye induced by topical administration of erlotinib eye drops |
| Q45880556 | A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model |
| Q36887538 | A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease |
| Q33837188 | A novel TRPM8 agonist relieves dry eye discomfort |
| Q36683616 | A novel fluorescent lipid probe for dry eye: retrieval by tear lipocalin in humans |
| Q33744602 | A novel noninvasive ocular surface analyzer for the assessment of dry eye with Meibomian gland dysfunction |
| Q55280295 | A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease. |
| Q35157303 | A pilot study: the efficacy of virgin coconut oil as ocular rewetting agent on rabbit eyes |
| Q36296284 | A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients |
| Q37417825 | A randomized controlled trial of omega-3 fatty acids in dry eye syndrome |
| Q64101752 | A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome |
| Q54222666 | A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye. |
| Q36908429 | A randomized, double-blind, placebo-controlled study of oral antioxidant supplement therapy in patients with dry eye syndrome. |
| Q35176597 | A review on recent advances in dry eye: Pathogenesis and management |
| Q36410618 | A single-center study evaluating the effect of the controlled adverse environment (CAE(SM)) model on tear film stability |
| Q36445561 | Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic Membrane |
| Q34409738 | Accumulation of secretory vesicles in the lacrimal gland epithelia is related to non-Sjögren's type dry eye in visual display terminal users. |
| Q35988343 | Accuracy of McMonnies Questionnaire as a Screening Tool for Chinese Ophthalmic Outpatients |
| Q36179631 | Activation of HIF-1α (hypoxia inducible factor-1α) prevents dry eye-induced acinar cell death in the lacrimal gland |
| Q64092315 | Acupuncture and dry eye: current perspectives. A double-blinded randomized controlled trial and review of the literature |
| Q38497754 | Acupuncture for dry eye: a multicentre randomised controlled trial with active comparison intervention (artificial tear drop) using a mixed method approach protocol |
| Q34277339 | Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops). |
| Q26863317 | Acupuncture therapy is more effective than artificial tears for dry eye syndrome: evidence based on a meta-analysis |
| Q47806771 | Advances in the analysis of "less-conventional" human body fluids: An overview of the CE- and HPLC-MS applications in the years 2015-2017. |
| Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
| Q37441381 | Age-related changes in the meibomian gland |
| Q34087380 | Age-related changes of the ocular surface: a hospital setting-based retrospective study |
| Q34273593 | Aging and dry eye disease |
| Q37276546 | Agreement of noninvasive tear break-up time measurement between Tomey RT-7000 Auto Refractor-Keratometer and Oculus Keratograph 5M. |
| Q60302700 | Air pollutant particulate matter 2.5 induces dry eye syndrome in mice |
| Q36179830 | Alcohol consumption and dry eye syndrome: a Meta-analysis |
| Q92066345 | Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis |
| Q57294883 | An Automated Grading and Diagnosis System for Evaluation of Dry Eye Syndrome |
| Q41094456 | An In Vitro Model for the Ocular Surface and Tear Film System |
| Q92462109 | An assessment of the ocular tear film in patients with thyroid disorders |
| Q60961948 | An experimental study of amniotic lacrimal duct stents in the treatment of perimenopausal female rabbits with dry eye |
| Q33790701 | Analysis of Clinical Characteristics of Immune-Related Dry Eye |
| Q36335761 | Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease |
| Q33595169 | Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome |
| Q58730456 | Analysis of basal and reflex human tear osmolarity in normal subjects: assessment of tear osmolarity |
| Q41574217 | Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface Disorders |
| Q36932301 | Angiogenin for the Diagnosis and Grading of Dry Eye Syndrome |
| Q53081062 | Anti-Inflammatory and Anti-Apoptotic Effects of Acer Palmatum Thumb. Extract, KIOM-2015EW, in a Hyperosmolar-Stress-Induced In Vitro Dry Eye Model. |
| Q42631353 | Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells |
| Q35863016 | Anti-inflammatory effects of hinokitiol on human corneal epithelial cells: an in vitro study |
| Q27026893 | Antimicrobial compounds in tears |
| Q35674674 | Application of a novel interferometric method to investigate the relation between lipid layer thickness and tear film thinning |
| Q64269461 | Apricot Kernel Extract and Amygdalin Inhibit Urban Particulate Matter-Induced Keratoconjunctivitis Sicca |
| Q33816037 | Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-Year Retrospective Study |
| Q36861178 | Are higher blood mercury levels associated with dry eye symptoms in adult Koreans? A population-based cross-sectional study |
| Q24561486 | Artificial tears potpourri: a literature review |
| Q57495675 | Assessing the relationship between non-invasive tear break-up time and maximum blink interval values among young adults at Mzuzu University |
| Q48498689 | Assessment and management of dry eye disease. |
| Q36304636 | Assessment of Corneal Biomechanical Properties by CorVis ST in Patients with Dry Eye and in Healthy Subjects |
| Q42044298 | Assessment of Tear Film Quality among Smokers Using Tear Ferning Patterns |
| Q60919214 | Assessment of tear-evaporation rate in thyroid-gland patients |
| Q64084419 | Assessment of the tear film in normal eye subjects after consumption of a single dose of hot peppermint drink |
| Q92189867 | Association Between Dry Eye Disease and Migraine Headaches in a Large Population-Based Study |
| Q37727457 | Association Between Serum 25-Hydroxyvitamin D Levels and Dry Eye in Korean Adults: A Study Based on Korean National Health and Nutrition Examination Survey, 2010-2011 |
| Q61804333 | Association between Three Heavy Metals and Dry Eye Disease in Korean Adults: Results of the Korean National Health and Nutrition Examination Survey |
| Q90348997 | Association between allergic conjunctivitis and provisional tic disorder in children |
| Q42940964 | Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome |
| Q90574523 | Association between dry eye symptoms and signs |
| Q33713187 | Association of dry eye disease with psychiatric or neurological disorders in elderly patients |
| Q26781979 | Associations between signs and symptoms of dry eye disease: a systematic review |
| Q35851088 | Atomic force microscopy and Langmuir-Blodgett monolayer technique to assess contact lens deposits and human meibum extracts |
| Q38176265 | Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca |
| Q48146337 | Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome |
| Q24200233 | Autologous serum eye drops for dry eye |
| Q24234791 | Autologous serum eye drops for dry eye syndrome |
| Q30235522 | Autologous serum eye drops for dry eye. |
| Q58887374 | Automatic Tear Film Segmentation Based on Texture Analysis and Region Growing |
| Q84866842 | Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye |
| Q47624172 | Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles. |
| Q33568598 | Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction. |
| Q26773937 | Biomaterials and Tissue Engineering Strategies for Conjunctival Reconstruction and Dry Eye Treatment |
| Q36499692 | Blueberry Component Pterostilbene Protects Corneal Epithelial Cells from Inflammation via Anti-oxidative Pathway |
| Q38712838 | Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye? |
| Q34211406 | CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease |
| Q50517284 | Calcium regulation by thermo- and osmosensing transient receptor potential vanilloid channels (TRPVs) in human conjunctival epithelial cells. |
| Q90746682 | Changes in Corneal Detection Thresholds After Repeated Tear Film Instability |
| Q41221760 | Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study |
| Q82488646 | Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria |
| Q36731499 | Changes of Corneal Wavefront Aberrations in Dry Eye Patients after Treatment with Artificial Lubricant Drops |
| Q38370253 | Characteristics of symptoms experienced by persons with dry eye disease while driving in China |
| Q42403998 | Characterization of Na+-K+-2Cl- Cotransporter Activity in Rabbit Lacrimal Gland Duct Cells. |
| Q59809188 | Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux |
| Q37067291 | Chronic dry eye disease is principally mediated by effector memory Th17 cells |
| Q97517778 | Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark - factors associated with risks and rates in adults according to conditioning regimen |
| Q37782084 | Clinical Review: Topical Ophthalmic Use of Cyclosporin A |
| Q28081416 | Clinical applications of anterior segment optical coherence tomography |
| Q87285237 | Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome |
| Q38733230 | Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting |
| Q49584457 | Clinical signs in cornea and ocular surface. |
| Q36291218 | Clinical study to assess the efficacy of Keshanjana and Netra Parisheka in the management of Shushkakshipaka (dry eye syndrome). |
| Q35647454 | Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes |
| Q39151688 | Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature |
| Q37376699 | Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours |
| Q42428108 | Comment on 'Corneal hysteresis in patients with dry eye'. |
| Q64227504 | Comparative Assessment of Tear Function Tests, Tear Osmolarity, and Conjunctival Impression Cytology between Patients with Pterygium and Healthy Eyes |
| Q33740130 | Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study |
| Q33553643 | Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis |
| Q92037608 | Comparison of Visual, Refractive and Ocular Surface Outcomes Between Small Incision Lenticule Extraction and Laser-Assisted In Situ Keratomileusis for Myopia and Myopic Astigmatism |
| Q49337437 | Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction. |
| Q33706060 | Comparison of corneal biomechanics in Sjögren's syndrome and non-Sjögren's syndrome dry eyes by Scheimpflug based device |
| Q33645315 | Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease |
| Q39835086 | Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial |
| Q36173201 | Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology |
| Q83832172 | Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel |
| Q36443965 | Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease. |
| Q36192148 | Comparison of the Schirmer I test with and without topical anesthesia for diagnosing dry eye |
| Q41231339 | Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops. |
| Q90403137 | Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study |
| Q26752848 | Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease |
| Q33572910 | Computed tear film and osmolarity dynamics on an eye-shaped domain |
| Q41170376 | Concentrations of MUC16 and MUC5AC using three tear collection methods |
| Q34412458 | Concordance between common dry eye diagnostic tests |
| Q37354234 | Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid |
| Q89339031 | Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction |
| Q36495510 | Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation |
| Q35904679 | Conjunctival impression cytology versus routine tear function tests for dry eye evaluation in contact lens wearers |
| Q99551013 | Connections between intrinsically photosensitive retinal ganglion cells and TBI symptomology |
| Q26750660 | Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface Diseases |
| Q36556824 | Corneal Dendritic Cell Density Is Associated with Subbasal Nerve Plexus Features, Ocular Surface Disease Index, and Serum Vitamin D in Evaporative Dry Eye Disease |
| Q35833720 | Corneal Epithelial Immune Dendritic Cell Alterations in Subtypes of Dry Eye Disease: A Pilot In Vivo Confocal Microscopic Study |
| Q46718255 | Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease |
| Q90426665 | Corneal epithelial thickness profile in dry-eye disease |
| Q42514475 | Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy |
| Q35248759 | Corneal nerve structure and function after long-term wear of fluid-filled scleral lens |
| Q35678783 | Corneal sensitivity following lacrimal gland excision in the rat. |
| Q37683370 | Correlation Analysis of Ocular Symptoms and Signs in Patients with Dry Eye. |
| Q48296048 | Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study |
| Q55187383 | Correlation between dry eye and refractive error in Saudi young adults using noninvasive Keratograph 4. |
| Q35422889 | Correlations between eyelid tumors and tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women |
| Q88128871 | Could corneal densitometry be used as a diagnostic and screening tool for ocular involvement in patients with gout? |
| Q39162548 | Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review |
| Q38235721 | Current Approach to Dry Eye Disease. |
| Q64900138 | Customary practices in the monitoring of dry eye disease in Sjogren's syndrome. |
| Q35572113 | Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study |
| Q54487191 | Cyclosporine in ocular surface inflammation. |
| Q35178892 | Cytokine changes in tears and relationship to contact lens discomfort |
| Q34789732 | Cytokine production and antigen recognition by human mucosal homing conjunctival effector memory CD8+ T cells |
| Q39492528 | Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells |
| Q37643220 | Dataset of longitudinal analysis of tear cytokine levels, CD4, CD8 counts and HIV viral load in dry eye patients with HIV infection |
| Q37472797 | Dataset of tear film cytokine levels in dry eye disease (DED) patients with and without HIV infection |
| Q30448957 | Decrease in hyperosmotic stress-induced corneal epithelial cell apoptosis by L-carnitine |
| Q42432373 | Decreased tear volume in patients with metabolic syndrome: the Osaka study |
| Q92465209 | Defining the needs and preferences of patients with dry eye disease |
| Q33908655 | Development and validation of the Chinese version of dry eye related quality of life scale |
| Q35717311 | Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients |
| Q26746232 | Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease |
| Q55020004 | Diabetic corneal neuropathy: clinical perspectives. |
| Q34092386 | Diagnosing the severity of dry eye: a clear and practical algorithm |
| Q27024827 | Diagnosis of dry eye disease and emerging technologies |
| Q34530644 | Diagnostic Performance of McMonnies Questionnaire as a Screening Survey for Dry Eye: A Multicenter Analysis |
| Q91405343 | Diagnostic Test Efficacy of Meibomian Gland Morphology and Function |
| Q100945976 | Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease |
| Q36908864 | Diagnostic performance of a tear protein panel in early dry eye |
| Q37027074 | Differences in Central Corneal Thickness between Spectral Domain-Optical Coherence Tomography and Ultrasound Pachymetry in Patients with Dry Eye Disease |
| Q37254870 | Differences in Dry Eye Questionnaire Symptoms in Two Different Modalities of Contact Lens Wear: Silicone-Hydrogel in Daily Wear Basis and Overnight Orthokeratology |
| Q37469958 | Differential contribution of hypertonic electrolytes to corneal epithelial dysfunction |
| Q30833462 | Differential effects of dry eye disorders on metabolomic profile by 1H nuclear magnetic resonance spectroscopy |
| Q37205958 | Differential scanning calorimetric evaluation of human meibomian gland secretions and model lipid mixtures: transition temperatures and cooperativity of melting |
| Q35629673 | Diquafosol ophthalmic solution 3 %: a review of its use in dry eye. |
| Q86003031 | Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition |
| Q34045629 | Direct observation and validation of fluorescein tear film break-up patterns by using a dual thermal-fluorescent imaging system |
| Q37536295 | Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). |
| Q34144866 | Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population based analysis |
| Q90451538 | Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial |
| Q64992035 | Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes: A Multicenter Study in South Korea. |
| Q55075449 | Does Dry Eye Affect Repeatability of Corneal Topography Measurements? |
| Q35226797 | Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation |
| Q93109216 | Dry Eye Analysis: A Citation Network Study |
| Q36407619 | Dry Eye Disease Incidence Associated with Chronic Graft-Host Disease: Nonconcurrent Cohort Study (An American Ophthalmological Society Thesis) |
| Q36009304 | Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility. |
| Q41816277 | Dry Eye Disease following Refractive Surgery: A 12-Month Follow-Up of SMILE versus FS-LASIK in High Myopia |
| Q35975632 | Dry Eye Disease in Patients with Functioning Filtering Blebs after Trabeculectomy |
| Q90415394 | Dry Eye Disease in Routine Rheumatology Practice |
| Q92824372 | Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits |
| Q34346990 | Dry Eye Disease: Impact on Quality of Life and Vision |
| Q36829070 | Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients. |
| Q33868853 | Dry Eye Syndrome in Menopause and Perimenopausal Age Group |
| Q86483090 | Dry eye and tear film functions in patients with psoriasis |
| Q36799601 | Dry eye disease and microbial keratitis: is there a connection? |
| Q37637612 | Dry eye disease in patients with metabolic syndrome |
| Q35655252 | Dry eye disease in type 2 diabetes mellitus; comparison of the tear osmolarity test with other common diagnostic tests: a diagnostic accuracy study using STARD standard |
| Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
| Q33870075 | Dry eye in LASIK patients |
| Q98611558 | Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker |
| Q37715859 | Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life |
| Q37685316 | Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway |
| Q47095515 | Dry eye signs and symptoms in night-time workers |
| Q26852044 | Dry eye: an inflammatory ocular disease |
| Q35190697 | Dynamics and function of the tear film in relation to the blink cycle |
| Q57461664 | Dynamics of Fluorescent Imaging for Rapid Tear Thinning |
| Q91993723 | Dyslipidemia and Meibomian Gland Dysfunction: Utility of Lipidomics and Experimental Prospects with a Diet-Induced Obesity Mouse Model |
| Q36858974 | Early changes to dry eye and ocular surface after small-incision lenticule extraction for myopia |
| Q88086011 | Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology |
| Q26770830 | Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review |
| Q35865215 | Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study |
| Q37155783 | Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes |
| Q36424981 | Effect of Stratification on Surface Properties of Corneal Epithelial Cells |
| Q37397109 | Effect of Three-Dimensional Printed Personalized Moisture Chamber Spectacles on the Periocular Humidity. |
| Q97536396 | Effect of a Natural Eye Drop, Made of Plantago Ovata Mucilage on Improvement of Dry Eye Symptoms: A Randomized, Double-blind Clinical Trial |
| Q35909249 | Effect of airflow exposure on the tear meniscus |
| Q37250982 | Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity |
| Q36758312 | Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis |
| Q37485814 | Effect of dihydrotestosterone on the expression of mucin 1 and the activity of Wnt signaling in mouse corneal epithelial cells |
| Q47777396 | Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye. |
| Q64971616 | Effect of laser acupuncture on dry eye: A study protocol for a 2-center randomized controlled trial. |
| Q46896696 | Effect of mistletoe combined with carboxymethyl cellulose on dry eye in postmenopausal women. |
| Q43252599 | Effect of nasolacrimal duct obstruction on nasal mucociliary transport |
| Q36582721 | Effect of pterygium surgery on tear osmolarity |
| Q92827375 | Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study |
| Q33686685 | Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients |
| Q36120878 | Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency |
| Q38686250 | Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery |
| Q35655084 | Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye. |
| Q37464380 | Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study |
| Q37280480 | Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study. |
| Q36292520 | Effects of 3% trehalose as an adjuvant treatment after LASIK. |
| Q36692399 | Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress |
| Q41056597 | Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium |
| Q37737978 | Effects of a warm compress containing menthol on the tear film in healthy subjects and dry eye patients. |
| Q37716339 | Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial |
| Q34919583 | Effects of age and dysfunction on human meibomian glands. |
| Q35214116 | Effects of corneal nerve density on the response to treatment in dry eye disease |
| Q92287239 | Effects of long-term computer use on eye dryness |
| Q39503936 | Effects of osmolarity on human epithelial conjunctival cells using an electrical technique |
| Q64058203 | Effects of short-term oral vitamin A supplementation on the ocular tear film in patients with dry eye |
| Q61443182 | Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes |
| Q88933158 | Efficacy and safety of acupuncture at a single BL1 acupoint in the treatment of moderate to severe dry eye disease: Protocol for a randomized, controlled trial |
| Q36940222 | Efficacy and safety of chondroitin sulfate/xanthan gum versus polyethylene glycol/propylene glycol/hydroxypropyl guar in patients with dry eye. |
| Q60307243 | Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study |
| Q40997622 | Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial |
| Q35507058 | Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial |
| Q35532014 | Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study |
| Q36280601 | Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis |
| Q47405249 | Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye. |
| Q92468052 | Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye |
| Q37163760 | Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction |
| Q64906418 | Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes. |
| Q36308741 | Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection |
| Q35205741 | Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye. |
| Q36044544 | Efficacy of topical blockade of interleukin-1 in experimental dry eye disease |
| Q34022299 | Efficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome model |
| Q34161118 | Efficacy of two-month treatment with Xiloial eyedrops for discomfort from disposable soft contact lenses |
| Q53122087 | Electrical stimulation of auricular acupressure for dry eye: A randomized controlled-clinical trial. |
| Q35201781 | Electrophoresis of tear proteins as a new diagnostic tool for two high risk groups for dry eye: computer users and contact lens wearers. |
| Q64057446 | Elevated cytokine levels in tears and saliva of patients with primary Sjögren's syndrome correlate with clinical ocular and oral manifestations |
| Q47137945 | Elevation of autophagy markers in Sjögren syndrome dry eye. |
| Q34371781 | Emerging treatment options for meibomian gland dysfunction |
| Q42694234 | Epigenetics in the Eye: An Overview of the Most Relevant Ocular Diseases |
| Q37462723 | Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease |
| Q37682316 | Essential fatty acids in the treatment of dry eye. |
| Q35008077 | Establishment of the mild, moderate and severe dry eye models using three methods in rabbits |
| Q37600492 | Estimating the Osmolarities of Tears During Evaporation Through the "Eyes" of the Corneal Nerves |
| Q37500497 | Etiology, diagnosis, management and outcomes of epiphora referrals to an oculoplastic practice |
| Q37288773 | Etiology, prevalence, and treatment of dry eye disease |
| Q41070931 | Evaluating Changes in Ocular Redness Using a Novel Automated Method |
| Q39816145 | Evaluating the Functionality of Conjunctiva Using a Rabbit Dry Eye Model. |
| Q38822811 | Evaluation of Accessory Lacrimal Gland in Muller's Muscle Conjunctival Resection Specimens for Precursor Cell Markers and Biological Markers of Dry Eye Disease |
| Q36531610 | Evaluation of Dry Eye and Meibomian Gland Dysfunction in Teenagers with Myopia through Noninvasive Keratograph |
| Q37717435 | Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure |
| Q37360878 | Evaluation of Ocular Surface Health in Patients with Obstructive Sleep Apnea Syndrome |
| Q58700419 | Evaluation of Reliability and Validity of Three Common Dry Eye Questionnaires in Chinese |
| Q36362131 | Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model |
| Q47098857 | Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye. |
| Q90479096 | Evaluation of a rat meibomian gland dysfunction model induced by closure of meibomian gland orifices |
| Q37444735 | Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose |
| Q92653082 | Evaluation of dry eye disease in newly diagnosed anxiety and depression patients using anterior segment optical coherence tomography |
| Q35796758 | Evaluation of dry eye findings in patients with vitiligo |
| Q92367624 | Evaluation of ocular surface impairment in meibomian gland dysfunction of varying severity using a comprehensive grading scale |
| Q37359850 | Evaluation of patients with dry eye disease for conjunctival Chlamydia trachomatis and Ureaplasma urealyticum |
| Q37219304 | Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. |
| Q90397161 | Evaluation of patients with dry eye for the presence of primary or secondary Sjӧgren's syndrome |
| Q34764807 | Evaluation of the adhesive properties of the cornea by means of optical coherence tomography in patients with meibomian gland dysfunction and lacrimal tear deficiency. |
| Q35177377 | Evidence for TRPA1 involvement in central neural mechanisms in a rat model of dry eye. |
| Q34662161 | Evidence for the major contribution of evaporation to tear film thinning between blinks. |
| Q47638923 | Evidence that dry eye is a comorbid pain condition in a U.S. veteran population |
| Q49544692 | Exercise program improved subjective dry eye symptoms for office workers. |
| Q49271262 | Experimental and Clinical Applications of Chamaecyparis obtusa Extracts in Dry Eye Disease. |
| Q35674608 | Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome |
| Q35919611 | Expression of SIRT1 and oxidative stress in diabetic dry eye. |
| Q37013881 | Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease |
| Q44255306 | Expression patterns of conjunctival mucin 5AC and aquaporin 5 in response to acute dry eye stress |
| Q58105209 | Factors Associated with Dry Eye Symptoms in Elderly Koreans: the Fifth Korea National Health and Nutrition Examination Survey 2010-2012 |
| Q60301127 | Factors influencing subjective symptoms in dry eye disease |
| Q33727595 | Fibroblast Growth Factor Receptor 2 (FGFR2) Is Required for Meibomian Gland Homeostasis in the Adult Mouse |
| Q34824116 | Fluorescein punctate staining traced to superficial corneal epithelial cells by impression cytology and confocal microscopy |
| Q35144078 | Fourier-domain optical coherence tomography for monitoring the lower tear meniscus in dry eye after acupuncture treatment |
| Q64058281 | Functional ectodermal organ regeneration as the next generation of organ replacement therapy |
| Q37152910 | Functions of ocular surface mucins in health and disease |
| Q43148458 | Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models |
| Q59796672 | Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief |
| Q50331845 | Gender differences in adolescent dry eye disease: a health problem in girls. |
| Q28274480 | Gene expression in human accessory lacrimal glands of Wolfring |
| Q35221347 | Gene expression profiling of early-phase Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes |
| Q37219269 | Glycogene expression in conjunctiva of patients with dry eye: downregulation of Notch signaling |
| Q36105424 | Goblet cell response after photorefractive keratectomy and laser in situ keratomileusis |
| Q37738181 | Grading criteria for chronic ocular graft-versus-host disease: comparing the NIH eye score, Japanese dry eye score, and DEWS 2007 score |
| Q38776423 | HIV-infected individuals on long-term antiretroviral therapy are at higher risk for ocular disease. |
| Q33861286 | HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease |
| Q35030126 | Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients |
| Q41573602 | Herbal Supplement in a Buffer for Dry Eye Syndrome Treatment |
| Q33748628 | High Frequency of Latent Conjunctival C. trachomatis, M. hominis, and U. urealyticum Infections in Young Adults with Dry Eye Disease |
| Q34056724 | High resolution microscopy of the lipid layer of the tear film. |
| Q37164943 | Hormone replacement therapy benefits meibomian gland dysfunction in perimenopausal women |
| Q64938744 | Human Lacrimal Production Rate and Wetted Length of Modified Schirmer's Tear Test Strips. |
| Q35893589 | Human Tear Serotonin Levels Correlate with Symptoms and Signs of Dry Eye |
| Q38187962 | Human lacrimal gland regeneration: Perspectives and review of literature |
| Q33623540 | Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life |
| Q50534206 | Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients. |
| Q36425043 | Hyperosmolar Tears Induce Functional and Structural Alterations of Corneal Nerves: Electrophysiological and Anatomical Evidence Toward Neurotoxicity |
| Q34677680 | Hyperosmolar stress induces neutrophil extracellular trap formation: implications for dry eye disease |
| Q34193504 | Hyperosmolar tears enhance cooling sensitivity of the corneal nerves in rats: possible neural basis for cold-induced dry eye pain |
| Q30513663 | Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro |
| Q36302713 | Hyperosmolarity-induced lipid droplet formation depends on ceramide production by neutral sphingomyelinase 2. |
| Q33686417 | Image-guided evaluation and monitoring of treatment response in patients with dry eye disease |
| Q90223560 | Impact of Dry Eye Disease on Vision Quality: An Optical Quality Analysis System Study |
| Q31072475 | Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population |
| Q56775843 | Impact of symptomatic dry eye on vision-related daily activities: The Singapore Malay Eye Study |
| Q26764956 | Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure |
| Q33621122 | Impression cytology implicates cell autophagy in aqueous deficiency dry eye. |
| Q36393194 | Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops |
| Q92669446 | Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up |
| Q52598288 | Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies. |
| Q36093656 | In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells |
| Q41628644 | In Vivo Confocal Microscopy Evaluation of Ocular Surface with Graft-Versus-Host Disease-Related Dry Eye Disease |
| Q91842559 | In Vivo Confocal Microscopy Observation of Cell and Nerve Density in Different Corneal Regions with Monocular Pterygium |
| Q26751496 | In Vivo Laser Scanning Confocal Microscopy of Human Meibomian Glands in Aging and Ocular Surface Diseases |
| Q51748290 | In Vivo Scanning Laser Confocal Microscopy of Conjunctival Goblet Cells in Medically-controlled Glaucoma. |
| Q35843885 | In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye Patients |
| Q26771221 | In pursuit of objective dry eye screening clinical techniques |
| Q62656894 | In vitro friction testing of contact lenses and human ocular tissues: Effect of proteoglycan 4 (PRG4) |
| Q99551257 | In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay |
| Q37445398 | In vivo Confocal Microscopy Evaluation of Meibomian Gland Dysfunction in Dry Eye Patients with Different Symptoms |
| Q27026571 | In vivo confocal microscopy in dry eye disease and related conditions |
| Q37649719 | In vivo confocal microscopy of the ocular surface: from bench to bedside |
| Q47139729 | In vivo imaging of palisades of Vogt in dry eye versus normal subjects using en-face spectral-domain optical coherence tomography |
| Q64054623 | Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A |
| Q35050334 | Incidence and pattern of dry eye after cataract surgery |
| Q92731229 | Incidence and pattern of dry eye after cataract surgery |
| Q33932282 | Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases |
| Q30579328 | Increased utilisation of eye disorder-related ambulatory medical services prior to the diagnosis of Sjögren's syndrome in female patients: a longitudinal population-based study in Taiwan. |
| Q47368616 | Inflammasomes, the eye and anti-inflammasome therapy. |
| Q37418879 | Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1% methylprednisolone |
| Q37078848 | Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model. |
| Q42280119 | Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells |
| Q54987431 | Influence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells. |
| Q52565313 | Influence of glaucoma surgery on the ocular surface using oculus keratograph. |
| Q58787880 | Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease |
| Q41015875 | Intense pulsed light for evaporative dry eye disease |
| Q36058512 | Inter-examiner reliability in meibomian gland dysfunction assessment. |
| Q41386825 | Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function. |
| Q41540895 | Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome |
| Q37177382 | Interleukin-1β and tumour necrosis factor-α levels in conjunctiva of diabetic patients with symptomatic moderate dry eye: case-control study |
| Q37365681 | International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). |
| Q28364856 | Interobserver variability of an open-source software for tear meniscus height measurement |
| Q35632214 | Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness |
| Q36623194 | Investigation of extended blinks and interblink intervals in subjects with and without dry eye. |
| Q38988352 | In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease |
| Q37308738 | Irritable bowel syndrome might be associated with dry eye disease |
| Q60047806 | Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests |
| Q34824257 | Isolation and propagation of mesenchymal stem cells from the lacrimal gland. |
| Q35690598 | Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study. |
| Q47439880 | JAK inhibition as a therapeutic strategy for immune and inflammatory diseases |
| Q48556502 | JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. |
| Q35633676 | JBP485 promotes tear and mucin secretion in ocular surface epithelia |
| Q33686673 | Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy. |
| Q39025675 | LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease |
| Q61446310 | Lacrimal passage irrigation in children with Stevens-Johnson syndrome or toxic epidermal necrolysis: a five-year retrospective study |
| Q21133793 | Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome |
| Q24320688 | Lacritin and other new proteins of the lacrimal functional unit |
| Q28287063 | Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells |
| Q39069560 | Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease |
| Q37591609 | Lifitegrast: A novel drug for treatment of dry eye disease |
| Q37457256 | Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome |
| Q37399828 | Lipoxin A4 Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells |
| Q50793003 | Local ocular surface parameters in patients with systemic celiac disease. |
| Q35529254 | Long-Term Outcome of Treatment with Topical Corticosteroids for Severe Dry Eye Associated with Sjögren's Syndrome |
| Q59034455 | Long-term effects of cataract surgery on tear film parameters |
| Q35223432 | Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. |
| Q86904838 | Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye |
| Q35064188 | Longitudinal assessment of optical quality and intraocular scattering using the double-pass instrument in normal eyes and eyes with short tear breakup time |
| Q36197694 | Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction |
| Q34352348 | Lost to follow-up for appointments in a dedicated dry eye clinic |
| Q64902241 | Lotrafilcon B with HydraGlyde moisture matrix or Samfilcon A: Contralateral comparison study for comfort. |
| Q35903232 | Low Serum 25-Hydroxyvitamin D Levels Are Associated with Dry Eye Syndrome |
| Q41862908 | Lower Vitamin D Level and Distinct Tear Cytokine Profile Were Observed in Patients with Mild Dry Eye Signs but Exaggerated Symptoms |
| Q24654945 | MUC16 expression in Sjogren's syndrome, KCS, and control subjects |
| Q26772031 | Making the diagnosis of Sjögren's syndrome in patients with dry eye |
| Q89986580 | Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series |
| Q48347591 | Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls |
| Q24619895 | Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells |
| Q47553490 | Mathematical modelling of glob-driven tear film breakup. |
| Q58599953 | Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease |
| Q40145537 | Maximum-likelihood estimation in Optical Coherence Tomography in the context of the tear film dynamics |
| Q41912312 | Measurement of a multi-layered tear film phantom using optical coherence tomography and statistical decision theory |
| Q37708819 | Measurement of the time course of optical quality and visual deterioration during tear break-up |
| Q47936168 | Mechanisms, imaging and structure of tear film breakup |
| Q37060242 | Meibography: A review of techniques and technologies |
| Q38811692 | Meibomian gland dysfunction patients with novel Sjögren's syndrome biomarkers benefit significantly from a single vectored thermal pulsation procedure: a retrospective analysis. |
| Q41493127 | Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome |
| Q53544019 | Meibomian gland loss due to trabeculectomy. |
| Q34063529 | Meibum lipid composition in Asians with dry eye disease |
| Q97886778 | Meibum lipid hydrocarbon chain branching and rheology after hematopoietic stem cell transplantation |
| Q38930001 | Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis. |
| Q36460492 | Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease |
| Q36097249 | Metabolic syndrome risk factors and dry eye syndrome: a Meta-analysis |
| Q91942374 | Metagenomics in ophthalmology: Hypothesis or real prospective? |
| Q80347912 | Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) |
| Q47093888 | Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome. |
| Q46412408 | Mitochondrial DNA oxidation induces imbalanced activity of NLRP3/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye. |
| Q35799409 | Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution |
| Q36625520 | Morphologic alterations of the palpebral conjunctival epithelium in a dry eye model |
| Q34057206 | Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy |
| Q64093364 | Multimodal Assessment of Corneal Erosions Using Optical Coherence Tomography and Automated Grading of Fluorescein Staining in a Rabbit Dry Eye Model |
| Q92297931 | NONINVASIVE TEAR FILM BREAK-UP TIME ASSESSMENT USING HANDHELD LIPID LAYER EXAMINATION INSTRUMENT |
| Q35196826 | Neuropathic ocular pain: an important yet underevaluated feature of dry eye. |
| Q47739620 | Neuropathic pain and dry eye. |
| Q35085293 | Neurostimulation of the lacrimal nerve for enhanced tear production |
| Q38840388 | New Treatment Guidelines for Sjögren's Disease |
| Q38058002 | New agents for treating dry eye syndrome. |
| Q33774520 | New testing options for diagnosing and grading dry eye disease |
| Q48236144 | Non-invasive assessment of tear film stability with a novel corneal topographer in Indian subjects. |
| Q39365232 | Non-invasive objective and contemporary methods for measuring ocular surface inflammation in soft contact lens wearers - A review. |
| Q89782794 | Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles |
| Q34650103 | Novel aspects of Sjögren's syndrome in 2012. |
| Q37783947 | Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye |
| Q35163639 | Nutritional supplements for dry eye syndrome |
| Q64075138 | Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes |
| Q92246579 | Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits |
| Q90182793 | Ocular Manifestations of Rheumatoid Arthritis: Implications of Recent Clinical Trials |
| Q36559274 | Ocular Surface Epithelial Thickness Evaluation in Dry Eye Patients: Clinical Correlations |
| Q64082082 | Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue |
| Q35049903 | Ocular complications of diabetes mellitus |
| Q101153045 | Ocular cytology: Diagnostic features and ongoing practices |
| Q35787569 | Ocular dryness excites two classes of corneal afferent neurons implicated in basal tearing in rats: involvement of transient receptor potential channels. |
| Q48510012 | Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation. |
| Q36550165 | Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India |
| Q35015847 | Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial |
| Q33865232 | Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis |
| Q47170651 | Ocular surface - a complex and vulnerable adoptive environment for topical glaucoma treatment |
| Q53663447 | Ocular surface changes after strabismus surgery with different incisions. |
| Q35067567 | Ocular surface disease in posttrabeculectomy/mitomycin C patients |
| Q37682318 | Ocular surface effects of thyroid disease. |
| Q36474926 | Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease |
| Q35907009 | Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease |
| Q81446047 | Ocular surface research at Alcon Laboratories |
| Q24198944 | Omega-3 and omega-6 polyunsaturated fatty acids for dry eye syndrome |
| Q33798707 | Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery |
| Q47916097 | On tear film breakup (TBU): dynamics and imaging |
| Q57479273 | Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease |
| Q53836361 | One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease. |
| Q33623447 | Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey. |
| Q41785810 | Optical Coherence Tomography Reveals Changes to Corneal Reflectivity and Thickness in Individuals with Tear Hyperosmolarity |
| Q55085239 | Optimizing acupuncture treatment for dry eye syndrome: a systematic review. |
| Q35542678 | Optimizing evaluation of Lissamine Green parameters for ocular surface staining. |
| Q42702543 | Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. |
| Q50991094 | Osmoprotective effects of supplemental epidermal growth factor in an ex vivo multilayered human conjunctival model under hyperosmotic stress. |
| Q52889021 | Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model. |
| Q24608339 | P2Y2 receptor agonists for the treatment of dry eye disease: a review |
| Q27340456 | PACAP suppresses dry eye signs by stimulating tear secretion |
| Q36444344 | PERSIST: Physician's Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review |
| Q57815890 | Pathogens in the Meibomian gland and conjunctival sac: microbiome of normal subjects and patients with Meibomian gland dysfunction |
| Q55064864 | Pathological conversion of regulatory T cells is associated with loss of allotolerance. |
| Q52608828 | Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye. |
| Q35010238 | Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction |
| Q61808996 | Patient-reported severity of dry eye and quality of life in diabetes |
| Q40775085 | Patients with more severe symptoms of neuropathic ocular pain report more frequent and severe chronic overlapping pain conditions and psychiatric disease |
| Q34080169 | Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus. |
| Q37079081 | Pharmacological management of dry eye in the elderly patient |
| Q52558847 | Phosphosulindac is efficacious in an improved concanavalin A-based rabbit model of chronic dry eye disease. |
| Q55312697 | Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma. |
| Q34342168 | Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation |
| Q42370585 | Possible association between subtypes of dry eye disease and seasonal variation |
| Q34102815 | Post-LASIK dry eye |
| Q33659714 | Post-LASIK tear dysfunction and dysesthesia |
| Q35213983 | Potential of the bioflavonoids in the prevention/treatment of ocular disorders |
| Q91905513 | Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease |
| Q27002082 | Practical issues concerning tear protein assays in dry eye |
| Q31007979 | Pre-corneal tear film thickness in humans measured with a novel technique |
| Q37453768 | Predicted phenotypes of dry eye: proposed consequences of its natural history. |
| Q36890721 | Prediction of risk and incidence of dry eye in critical patients |
| Q47381165 | Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. |
| Q39348004 | Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice |
| Q41708097 | Prevalence and Risk Factors of Dry Eye Symptoms in a Saudi Arabian Population |
| Q47547213 | Prevalence and Risk Factors of self-reported dry eye in Brazil using a short symptom questionnaire |
| Q36537077 | Prevalence and associated factors of dry eye: Our experience in patients above 40 years of age at a Tertiary Care Center |
| Q55122175 | Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study. |
| Q33720070 | Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies |
| Q34383016 | Prevalence of dry eye syndrome after a three-year exposure to a clean room |
| Q36079176 | Prevalence of dry eye syndrome in residents of surgical specialties |
| Q37423611 | Prevalence of ocular surface disease symptoms and risk factors in group of university students in Monterrey, Mexico |
| Q54956654 | Prevention, diagnosis & management of dry eye in South Asia. |
| Q36676823 | Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome |
| Q35979980 | Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells |
| Q37110777 | Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients |
| Q34682290 | Punctal occlusion for dry eye syndrome |
| Q58781979 | Quality of life measures and health utility values among dry eye subgroups |
| Q36779350 | Quantitative analysis of tear film fluorescence and discomfort during tear film instability and thinning |
| Q36533284 | Quantitative characterization reveals three types of dry-sensitive corneal afferents: pattern of discharge, receptive field, and thermal and chemical sensitivity. |
| Q81672175 | Quantitative videographic analysis of blink patterns of newscasters |
| Q52889830 | Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation. |
| Q37623843 | Randomized, masked, in vitro comparison of three commercially available tear film osmometers |
| Q37610134 | Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome. |
| Q58887368 | Real-Time Tear Film Classification Through Cost-Based Feature Selection |
| Q91827428 | Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye |
| Q58713024 | Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease |
| Q41786140 | Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study |
| Q64066727 | Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice |
| Q33734688 | Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal |
| Q35579883 | Reduced Corneal Endothelial Cell Density in Patients With Dry Eye Disease |
| Q50034049 | Relation Between Dietary Essential Fatty Acid Intake and Dry Eye Disease and Meibomian Gland Dysfunction in Postmenopausal Women. |
| Q92239871 | Relationship between Ocular Surface Alterations and Concentrations of Aerial Particulate Matter |
| Q91940005 | Relationship between dry eye and glycosylated haemoglobin among diabetics in Ibadan, Nigeria |
| Q90263129 | Relationship between lipid layer thickness, incomplete blinking rate and tear film instability in patients with different myopia degrees after small-incision lenticule extraction |
| Q36222687 | Relationship between symptoms of dry eye syndrome and occupational characteristics: the Korean National Health and Nutrition Examination Survey 2010-2012. |
| Q43119649 | Relevance of Lipid-Based Products in the Management of Dry Eye Disease |
| Q53460998 | Reliability of a new modified tear breakup time method: dry tear breakup time. |
| Q36835236 | Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease |
| Q80347923 | Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007) |
| Q34206447 | Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride |
| Q36222177 | Resolution of persistent corneal erosion after administration of topical rebamipide |
| Q42339162 | Resolution of pinguecula-related dry eye disease after argon laser photocoagulation |
| Q28073034 | Resolvins and aliamides: lipid autacoids in ophthalmology - what promise do they hold? |
| Q35009043 | Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye. |
| Q35797137 | Role of epithelial-mesenchymal transition in repair of the lacrimal gland after experimentally induced injury |
| Q55436548 | SFTA3 - a novel surfactant protein of the ocular surface and its role in corneal wound healing and tear film surface tension. |
| Q64080815 | SNP variations in IL10, TNFα and TNFAIP3 genes in patients with dry eye syndrome and Sjogren's syndrome |
| Q36617867 | Safety and comfort evaluation of a new formulation of Visine(®) lubricant eye drops containing HydroBlend™ and GentlePur™ |
| Q41316622 | Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. |
| Q33825538 | Safety and efficacy of cyclosporine in the treatment of chronic dry eye. |
| Q37131445 | Scale and spatial distribution of aberrations associated with tear breakup |
| Q40953641 | Self versus examiner administration of the Ocular Surface Disease Index© |
| Q45952791 | Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease. |
| Q36141209 | Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease--A Prospective, Multicenter Noninterventional Study |
| Q64230565 | Shared Medical and Environmental Risk Factors in Dry Eye Syndrome, Sjogren's Syndrome, and B-Cell Non-Hodgkin Lymphoma: A Case-Control Study |
| Q85115798 | Simultaneous examination of tear film break-up and the lipid layer of the human eye: a novel sensor design (Part 1) |
| Q39019614 | Sjögren Syndrome and Other Causes of Sicca in Older Adults |
| Q37603853 | Sjögren's syndrome: An underdiagnosed condition in mixed connective tissue disease |
| Q36634380 | Sleep and mood disorders in dry eye disease and allied irritating ocular diseases. |
| Q37330361 | Sleep and mood disorders in women with dry eye disease |
| Q36812082 | Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease |
| Q30826797 | Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study |
| Q37359864 | Smoking and the risk of dry eye: a Meta-analysis |
| Q55009793 | Sodium Fluorescein Staining of the Cornea for the Diagnosis of Dry Eye: A Comparison of Three Eye Solutions. |
| Q41489266 | Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis |
| Q24282614 | Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome |
| Q34070100 | Spatial epidemiology of dry eye disease: findings from South Korea |
| Q34989629 | Staphylococcus aureus activates the NLRP3 inflammasome in human and rat conjunctival goblet cells |
| Q37084310 | Static and Dynamic Measurement of Ocular Surface Temperature in Dry Eyes. |
| Q33760855 | Structure and biological roles of mucin-type O-glycans at the ocular surface |
| Q47134597 | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye. |
| Q38674125 | Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds |
| Q83682081 | Surgical management of lacrimal punctal cauterization in chronic GVHD-related dry eye with recurrent punctal plug extrusion |
| Q49712793 | Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren Syndrome. |
| Q38655662 | Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects |
| Q36197724 | Symptoms of Dry Eye Disease and Personality Traits |
| Q28552083 | Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome |
| Q37900496 | Systane lubricant eye drops in the management of ocular dryness |
| Q37686712 | T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration |
| Q38652990 | TFOS DEWS II Tear Film Report. |
| Q39453338 | TFOS DEWS II pain and sensation report. |
| Q52687757 | Tear Film Osmolarity in Subjects with Acute Allergic Rhinoconjunctivitis. |
| Q41181275 | Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry. |
| Q57793257 | Tear Luminex Analysis in Dry Eye Patients |
| Q92372126 | Tear Metabolomics in Dry Eye Disease: A Review |
| Q37370475 | Tear Osmolarity, Break-up Time and Schirmer's Scores in Parkinson's Disease |
| Q55174805 | Tear Volume-based Diagnostic Classification for Tear Dysfunction. |
| Q33869200 | Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease |
| Q28393435 | Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures |
| Q30541748 | Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images |
| Q33655642 | Tear film dynamics with evaporation, wetting, and time-dependent flux boundary condition on an eye-shaped domain |
| Q36257052 | Tear film osmolarity and dry eye disease: a review of the literature |
| Q26740411 | Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine |
| Q37386334 | Tear fluid extracellular DNA: diagnostic and therapeutic implications in dry eye disease |
| Q82619628 | Tear function and lipid layer alterations in dry eye patients with chronic graft-vs-host disease |
| Q50034015 | Tear instability importance, mechanisms, validity and reliability of assessment. |
| Q30422186 | Tear lacritin levels by age, sex, and time of day in healthy adults |
| Q36041432 | Tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women |
| Q92543230 | Tear osmolarity after cataract surgery |
| Q37641850 | Tear osmolarity and dry eye symptoms in diabetics. |
| Q36675162 | Tear osmolarity and dry eye symptoms in women using oral contraception and contact lenses |
| Q83557600 | Tear physiology in dry eye associated with chronic GVHD |
| Q47112214 | Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation |
| Q36921555 | Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients |
| Q61811564 | TearCare system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare treatment on subjects with dry eye disease |
| Q36811289 | The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy |
| Q36989827 | The Association between Symptoms of Dry Eye Syndrome and Metabolic Outcome in a General Population in Korea |
| Q45326881 | The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US Veterans |
| Q48173887 | The Berkeley Dry Eye Flow Chart: A fast, functional screening instrument for contact lens-induced dryness. |
| Q38750436 | The Blockade of IL6 Counterparts the Osmolar Stress-Induced Apoptosis in Human Conjunctival Epithelial Cells. |
| Q61799629 | The Bull's Eye Pattern of the Tear Film in Humans during Visual Fixation on En-Face Optical Coherence Tomography |
| Q36926074 | The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease |
| Q50665912 | The Conjunctiva-Associated Lymphoid Tissue in Chronic Ocular Surface Diseases. |
| Q55115758 | The Correlation between Daily Lens Wear Duration and Dry Eye Syndrome. |
| Q26776174 | The Effect of Hormone Replacement Therapy on Dry Eye Syndrome Evaluated with Schirmer Test and Break-Up Time |
| Q40238995 | The Effects of Hemodialysis on Tear Osmolarity |
| Q35831276 | The Effects of Increasing Ocular Surface Stimulation on Blinking and Tear Secretion |
| Q55515186 | The Eye, Oxidative Damage and Polyunsaturated Fatty Acids. |
| Q33756582 | The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research |
| Q37689580 | The Human Eye Proteome Project: perspectives on an emerging proteome |
| Q36039088 | The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye |
| Q38724515 | The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye |
| Q47884949 | The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research |
| Q41405231 | The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye. |
| Q38140831 | The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology |
| Q64058209 | The acute effect of a single dose of green tea on the quality and quantity of tears in normal eye subjects |
| Q34385610 | The aging lacrimal gland: changes in structure and function. |
| Q41909205 | The anatomical and functional relationship between allergic conjunctivitis and allergic rhinitis |
| Q33765579 | The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease. |
| Q98196752 | The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling |
| Q37641435 | The association between symptoms of discomfort and signs in dry eye. |
| Q35970088 | The association of vitamin D deficiency with tear break-up time and Schirmer testing in non-Sjögren dry eye. |
| Q37233339 | The challenge of dry eye diagnosis |
| Q34510429 | The core mechanism of dry eye disease is inflammation |
| Q48169068 | The correlation between plasma osmolarity and tear osmolarity |
| Q37644779 | The correlation of routine tear function tests and conjunctival impression cytology in dry eye syndrome. |
| Q36483107 | The dominant human conjunctival epithelial CD8αβ+ T cell population is maintained with age but the number of CD4+ T cells increases |
| Q55527700 | The dry eye disease activity log study. |
| Q41484441 | The effect of intravitreal injections on dry eye, and proposed management strategies |
| Q43124441 | The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study. |
| Q36872338 | The effect of topical cyclosporine 0.05% on dry eye after cataract surgery |
| Q37637160 | The effects of increasing ocular surface stimulation on blinking and sensation |
| Q34005463 | The effects of mild ocular surface stimulation and concentration on spontaneous blink parameters |
| Q52768652 | The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases. |
| Q38219053 | The eye: a window of opportunity in rheumatoid arthritis? |
| Q48458104 | The first definition of Sjögren's syndrome. |
| Q39347374 | The function of regulatory T cells at the ocular surface: Review. |
| Q34511150 | The heritability of dry eye disease in a female twin cohort |
| Q49487998 | The improvement of dry eye after cataract surgery by intraoperative using ophthalmic viscosurgical devices on the surface of cornea: The results of a consort-compliant randomized controlled trial. |
| Q37000745 | The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study. |
| Q58728087 | The inflammation influence on corneal surface after frontalis suspension surgery |
| Q34769324 | The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee |
| Q34769313 | The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee |
| Q34769319 | The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction |
| Q34769309 | The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q83697447 | The patient's experience of blepharitis |
| Q38901538 | The potential role of neuropathic mechanisms in dry eye syndromes |
| Q88362505 | The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population |
| Q34871250 | The relationship between Graves' ophthalmopathy and dry eye syndrome |
| Q37569862 | The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals |
| Q38270449 | The role and treatment of inflammation in dry eye disease |
| Q41352146 | The role of lipids in corneal diseases and dystrophies: a systematic review |
| Q24649593 | The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis) |
| Q37143007 | The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye. |
| Q37801992 | The tear film and the optical quality of the eye. |
| Q36177590 | The use of fluorescent quenching in studying the contribution of evaporation to tear thinning |
| Q36985541 | Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye. |
| Q26822610 | Therapeutic Strategies to Treat Dry Eye in an Aging Population |
| Q36224854 | Therapeutic efficacy of fibroblast growth factor 10 in a rabbit model of dry eye. |
| Q35768484 | Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system |
| Q36048835 | Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome |
| Q46689617 | Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model |
| Q37721598 | Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease |
| Q88390839 | Tolerability of Topical Tocilizumab Eyedrops in Dogs: A Pilot Study |
| Q35411110 | Toll-like receptor 2-mediated NF-κB inflammatory responses in dry eye associated with cGVHD |
| Q92504651 | Topical Application of Liriope platyphylla Extract Attenuates Dry Eye Syndrome Induced by Particulate Matter |
| Q55153508 | Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial. |
| Q36413214 | Topical administration of Esculetin as a potential therapy for experimental dry eye syndrome |
| Q37195776 | Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease. |
| Q24563932 | Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease |
| Q34066784 | Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study |
| Q33583080 | Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations |
| Q40444348 | Topical cyclosporine a for mustard gas induced ocular surface disorders |
| Q35087001 | Topical cyclosporine a for treatment of dry eye due to chronic mustard gas injury |
| Q35748985 | Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications |
| Q34206399 | Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. |
| Q45919311 | Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD. |
| Q37460389 | Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface |
| Q47155411 | Treatment of Dry Eye Disease with Autologous Platelet-Rich Plasma: A Prospective, Interventional, Non-Randomized Study. |
| Q37236096 | Treatment of chronic dry eye: focus on cyclosporine |
| Q33543585 | Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial |
| Q37257722 | Treatment of patients with keratoconjunctivitis sicca with Optive: results of a multicenter, open-label observational study in Germany. |
| Q55009490 | Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. |
| Q38787674 | Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease. |
| Q56363589 | Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients |
| Q48265701 | Trigeminal brainstem modulation of persistent orbicularis oculi muscle activity in a rat model of dry eye. |
| Q36911922 | Trigeminal stereotactic electrolysis induces dry eye in mice |
| Q37140684 | Triple classification of diagnosis of dry eyes. |
| Q46443810 | Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist |
| Q57214324 | Uncorrected visual acuity, postoperative astigmatism, and dry eye symptoms are major determinants of patient satisfaction: a comparative, real-life study of femtosecond laser in situ keratomileusis and small incision lenticule extraction for myopia |
| Q37210882 | Understanding the true burden of dry eye disease |
| Q90003803 | Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults |
| Q90403120 | Update on the role of impression cytology in ocular surface disease |
| Q33802192 | Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface |
| Q42125064 | Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction. |
| Q33800691 | Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia |
| Q30421187 | Use of umbilical cord serum in ophthalmology |
| Q58804205 | Useful In Vitro Techniques to Evaluate the Mucoadhesive Properties of Hyaluronic Acid-Based Ocular Delivery Systems |
| Q90696025 | Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease |
| Q41112861 | Validation of Farsi Translation of the Ocular Surface Disease Index |
| Q41913821 | Validity of subjective assessment as screening tool for dry eye disease and its association with clinical tests |
| Q35962831 | Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis |
| Q56978743 | Visions of Eye Commensals: The Known and the Unknown About How the Microbiome Affects Eye Disease |
| Q37307601 | Vitamin D Supplementation for Patients with Dry Eye Syndrome Refractory to Conventional Treatment. |
| Q35588916 | Vitamin D: Implications for ocular disease and therapeutic potential |
| Q38053596 | Wakayama Symposium: Peroxisome proliferator-activated receptor-gamma (PPARγ) and meibomian gland dysfunction |
| Q35906101 | Wakayama symposium: interface between innate and adaptive immunity in dry eye disease |
| Q87404739 | [Comparison of the OSDI and SPEED questionnaires for the evaluation of dry eye disease in clinical routine] |
| Q86977928 | [Contact lens associated dry eye. Current study results and practical implementation] |
| Q86977924 | [Contact lenses from the perspective of ophthalmologists] |
| Q88884763 | [Diagnosis and treatment of the watering eye] |
| Q52322805 | [Diagnosis of dry eye disease]. |
| Q85963889 | [Eyelid hygiene for contact lens wearers with blepharitis. Comparative investigation of treatment with baby shampoo versus phospholipid solution] |
| Q83395307 | [The "wet" dry eye] |
| Q94521239 | miR-744-5p contributes to ocular inflammation in patients with primary Sjogrens Syndrome |
| Q24635932 | sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model |
| Q36388893 | α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways |
Search more.